Skip to main content
Premium Trial:

Request an Annual Quote

CBI to Evaluate Zygem's DNA Extraction Technology

NEW YORK (GenomeWeb News) – Zygem said today that Commonwealth Biotechnologies will evaluate how Zygem’s forensicGEM DNA extraction technology works in CBI's forensic operations.
 
Under the collaboration, CBI is integrating the forensicGEM kits into its Fairfax Identity Laboratories, which analyzes forensic samples and develops enhanced forensic testing procedures.
 
Zygem’s forensicGEM kits use a proprietary enzyme to extract DNA from samples that use a single closed-tube system, an approach that the company said, “simplifies laboratory workflow, minimizes error, reduces the risk of contamination, and ensures sample integrity while also reducing costs.”
 
The kits are formulated for DNA extraction from “a range of different crime sample types without the need for further purification,” the company said.
 
Financial terms of the agreement were not released.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.